The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β2-microglobulin genes

Immunity

Volumn 9, Issue 4, 1998, Pages 531-541

  Gobin, Sam J P ^a   Peijnenburg, Ad ^a   Van Eggermond, Marja ^a   Van Zutphen, Marlijn ^a   Van Den Berg, Rian ^a   Van Den Elsen, Peter J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032192508     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80636-6     Document Type: Article

References (51)

1. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular responses to interferon-γ. Annu. Rev. Immunol. 15, 749-795.
2. Boss, J.M. (1997). Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9, 107-113.
3. Carey, M. (1998). The enhanceosome and transcriptional synergy. Cell 92, 5-8.
4. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
5. Dey, A., Thornton, A.M., Lonergan, M., Weissman, S.M., Chamberlain, J.W., and Ozato, K. (1992). Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell. Biol. 12, 3590-3599.
6. Drew, P.D., Franzoso, G., Becker, K.G., Bours, V., Carlson, L.M., Siebenlist, U., and Ozato, K. (1995). NFκB and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15, 1037-1045.
7. Durand, B., Sperisen, P., Emery, P., Barra, E., Zufferey, M., Mach, B., and Reith, W. (1997). RFXAP, a novel subunit of the RFX DNA binding complex is mutated in class II deficiency. EMBO J. 16, 1045-1055.
8. Flajnik, M.F., Canel, C., Kramer, J., and Kasahara, M. (1991). Which came first, MHC class I or MHC class II? Immunogenetics 33, 295-300.
9. Fontes, J.D., Jabrane-Ferrat, N., and Peterlin, B.M. (1997a). Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270, 336-345.
10. II32. Nucleic Acid Res. 25, 2522-2528.
11. Gaur, L.K., Heise, E.R., and Ting, J.P. (1992). Conservation of the promoter region of DRA-like genes from nonhuman primates. Immunogenetics 35, 136-139.
12. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
13. Girdlestone, J., Isamat, M., Gewert, D., and Milstein, C. (1993). Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proc. Natl. Acad. Sci. USA 90, 11568-11572.
14. Gobin, S.J.P., Peijnenburg, A., Keijsers, V., and Van den Elsen, P.J. (1997). Site a is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6, 601-611.
15. Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., and Ploegh, H.L. (1987). The human β2-microglobulin gene. Primary structure and definition of the transcriptional unit. J. Immunol. 139, 3132-3138.
16. Israel, A., Kimura, A., Kieran, M., Yano, O., Kanellopoulos, J., Le Bail, O., and Kourilsky, P. (1987). A common positive trans-acting factor binds to enhancer sequences in the promoter of mouse H-2 and β2-microglobulin genes. Proc. Natl. Acad. Sci. USA 84, 2653-2657.
17. Jabrane-Ferrat, N., Fontes, J.D., Boss, J.M., and Peterlin, B.M. (1996). Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16, 4683-4690.
18. Johnson, D.R., and Pober, J.S. (1994). HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14, 1322-1332.
19. Kaufman, J., Salomonsen, J., and Flajnik, M. (1994). Evolutionary conservation of MHC class I and class II molecules - different yet the same. Semin. Immunol. 6, 411-424.
20. Kim, T.K., and Maniatis, T. (1998). The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1, 119-129.
21. Kroemer, G., Zoorob, R., and Auffrey, C. (1990). Structure and expression of a chicken MHC class I gene. Immunogenetics 31, 405-409.
22. Lambert, M., Van Eggermond, M., Andrien, M., Mascart, F., Vamos, E., Dupont, E., and Van den Elsen, P.J. (1991). Analysis of the peripheral T-cell compartment in the MHC class II deficiency syndrome. Res. Immunol. 142, 789-798.
23. Le Bouteiller, P. (1994). HLA class I chromosomal region, genes, and products: facts and questions. Crit. Rev. Immunol. 14, 89-129.
24. Lonergan, M., Dey, A., Becker, K.G., Drew, P.D., and Ozato, K. (1993). A regulatory element in the β2-microglobulin promoter identified by in vivo footprinting. Mol. Cell. Biol. 13, 6629-6639.
25. Louis-Plence, P.L., Moreno, C.S., and Boss, J.M. (1997). Formation of a regulatory factor X/X2 Box-binding protein nuclear factor-Y multiprotein complex on the conserved regulatory regions on HLA class II genes. J. Immunol. 159, 3899-3909.
26. Mach, B., Steimle, V., Martinez-Soria, E., and Reith, W. (1996). Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14, 301-331.
27. Mahanta, S.K., Scholl, T., Yang, F.C., and Strominger, J.L. (1997). Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94, 6324-6329.
28. Mansky, P., Brown, W.M., Park, J.-H., Choi, J.W., and Yang, S.Y. (1994). The second κB element, κB2, of the HLA-A class I regulatory complex is an essential part of the promoter. J. Immunol. 153, 5082-5090.
29. Martin, B.K., Chin, K.-C., Olsen, J.C., Skinner, C.A., Dey, A., Ozato, K., and Ting, J.Y.-P. (1997). Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6, 591-600.
30. Moreno, C.S., Emery, P., West, J.E., Durand, B., Reith, W., Mach, B., and Boss, J.M. (1995). Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155, 4313-4321.
31. Moreno, C.S., Rogers, E.M., Brown, J.A., and Boss, J.M. (1997). Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158, 5841-5848.
32. Ono, H., Figueroa, F., O'Huigin, C., and Klein, K.A. (1993). Cloning of the beta 2-microglobulin in the zebrafish. Immunogenetics 38, 1-10.
33. Peijnenburg, A., Godthelp, B., Van Boxel-Dezaire, A., and Van den Elsen, P.J. (1995). Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41, 287-294.
34. Peijnenburg, A., Gobin, S.J., Van Eggermond, M.C., Godthelp, B.C., Van Graafeiland, N., and Van den Elsen, P.J. (1997). Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. J. Immunol. 159, 2720-2727.
35. Reith, W., Siegrist, C.-A., Durand, B., Barras, E., and Mach, B. (1994). Function of major histocompatibility complex II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91, 554-558.
36. Riegert, P., Andersen, R., Bumstead, N., Döhring, C., Dominguez-Steglich, M., Engberg, J., Salomonsen, J., Schmid, M., Schwager, J., Skjødt, K., and Kaufman, J. (1996). The chicken β2-microblobulin gene is located on a non-major histocompatibility complex microchromosome: A small, G + C-rich gene with X and Y boxes in the promoter. Proc. Natl. Acad. Sci. USA 93, 1243-1248.
37. Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A., and Boss, J.M. (1995). Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2, 533-543.
38. Sabatier, C., Gimenez, C., Calin-Laurens, V., Rabourdin-Combe, C., and Touraine, J.-L. (1996). Type III bare lymphocyte syndrome: lack of HLA class II gene expression and reduction in HLA class I gene expression. CR Acad. Sci. III 319, 789-798.
39. Salter-Cid, L., and Flajnik, M.F. (1995). Evolution and developmental regulation of the major histocompatibility complex. Crit. Rev. Immunol. 15, 31-75.
40. Scholl, T., Mahanta, S.K., and Strominger, J.L. (1997). Specific complex formation between the type II bare lymphocyte syndrome-associated transactivator CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94, 6330-6334.
41. Schoneich, J., Lee, J.L., Mansky, P., Sheffery, M., and Yang, S.Y. (1997). The pentanucleotide ATTGG, the "inverted CCAAT," is an essential element for HLA class I gene transcription. J. Immunol. 158, 4788-4796.
42. Silacci, P., Mottet, A., Steimle, V., Reith, W., and Mach, B. (1994). Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180, 1329-1336.
43. Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
44. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M.R., Mach, B., and Reith, W. (1995). A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9, 1021-1032.
45. Ting, J.P.-Y., and Baldwin, A.S. (1993). Regulation of MHC gene expression. Curr. Opin. Immunol. 5, 8-16.
46. Touraine, J.-L., Marseglia, G.-L., and Betuel, H. (1985). Thirty international cases of bare lymphocyte syndrome: biological significance of HLA antigens. Exp. Hematol. 13, 86-87.
47. Vallejo, A.N., and Pease, L.R. (1995). Evolution of class I promoter sequences: relationship to function and diversity. Immunol. Rev. 143, 249-262.
48. Villard, J., Lisowska-Grospierre, B., Van den Elsen, P., Fischer, A., Reith, W., and Mach, B. (1997). Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337, 748-753.
49. Wright, K.L., Vilen, B.J., Itoh-Lindstrom, Y., Moore, T.L., Li, G., Criscitiello, M., Cogswell, P., Clarke, J.B., and Ting, J.P.-Y. (1994). CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13, 4042-4053.
50. Zeleznik-Le, N., Azizkhan, J.C., and Ting, J.P.-Y. (1991). Affinity purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88, 1873-1877.
51. Zhou, H., and Glimcher, L.H. (1995). Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2, 545-553.